Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2017
Time to Second-line Treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaEric M Ammann, Tait D Shanafelt, Melissa C Larson, et al.
Medicine|July 24, 2019
Assessment of obesity prevalence and validity of obesity diagnoses coded in claims data for selected surgical populations: A retrospective, observational studyEric M Ammann, Iftekhar Kalsekar, Andrew Yoo, et al.
Heliyon|February 27, 2023
Characteristics, management, and blood pressure control in patients with apparent resistant hypertension in the USEric M Ammann, Ellen S O'Brien, Dejan Milentijevic, et al.
Cancer|June 28, 2017
Incidence of hematologic malignancy and cause-specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementationEric M Ammann, Matthew T Drake, Bjarni Haraldsson, et al.
Advances in Therapy|March 18, 2024
Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level DataBrian G M Durie, Shaji K Kumar, Eric M Ammann, et al.
Neurology|September 27, 2013
ω-3 fatty acids and domain-specific cognitive aging: secondary analyses of data from WHISCAEric M Ammann, James V Pottala, William S Harris, et al.
International Journal of Geriatric Psychiatry|December 17, 2013
Omega-3 fatty acid biomarkers and subsequent depressive symptomsJane E Persons, Jennifer G Robinson, Eric M Ammann, et al.
Obesity (Silver Spring, Md.)|April 8, 2018
Prevalence and Determinants of Engagement with Obesity Care in the United StatesAndrew Stokes, Jason M Collins, Bethany F Grant, et al.
Diabetes Care|March 7, 2018
Obesity Progression Between Young Adulthood and Midlife and Incident Diabetes: A Retrospective Cohort Study of U.S. AdultsAndrew Stokes, Jason M Collins, Bethany F Grant, et al.
American Journal of Hematology|August 18, 2020
Daratumumab-lenalidomide-dexamethasone vs standard-of-care regimens: Efficacy in transplant-ineligible untreated myelomaBrian G M Durie, Shaji K Kumar, Saad Z Usmani, et al.
Pageof 3